Sébastien Viel

11.8k total citations · 3 hit papers
64 papers, 3.6k citations indexed

About

Sébastien Viel is a scholar working on Immunology, Molecular Biology and Rheumatology. According to data from OpenAlex, Sébastien Viel has authored 64 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 12 papers in Molecular Biology and 10 papers in Rheumatology. Recurrent topics in Sébastien Viel's work include Immune Cell Function and Interaction (21 papers), T-cell and B-cell Immunology (11 papers) and Food Allergy and Anaphylaxis Research (8 papers). Sébastien Viel is often cited by papers focused on Immune Cell Function and Interaction (21 papers), T-cell and B-cell Immunology (11 papers) and Food Allergy and Anaphylaxis Research (8 papers). Sébastien Viel collaborates with scholars based in France, United States and Netherlands. Sébastien Viel's co-authors include Thierry Walzer, Antoine Marçais, Christine Assaiante, Thomas Henry, Jacques Bienvenu, Jacqueline Marvel, Alexandre Bélot, Emily Charrier, Sophie Degouve and Katia Mayol and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Annals of Internal Medicine.

In The Last Decade

Sébastien Viel

60 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway

2016 493 citations Sébastien Viel, Antoine Marçais et al. profile →
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions

2020 474 citations Yvan Jamilloux, Thomas Henry et al. profile →
The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells

2014 462 citations Antoine Marçais, Sébastien Viel et al. profile →

Peers

Countries citing papers authored by Sébastien Viel

Since Specialization

Citations

This map shows the geographic impact of Sébastien Viel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sébastien Viel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sébastien Viel more than expected).

Fields of papers citing papers by Sébastien Viel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sébastien Viel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sébastien Viel. The network helps show where Sébastien Viel may publish in the future.

Co-authorship network of co-authors of Sébastien Viel

This figure shows the co-authorship network connecting the top 25 collaborators of Sébastien Viel. A scholar is included among the top collaborators of Sébastien Viel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sébastien Viel. Sébastien Viel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Profiling type I and II interferon responses reveals distinct subgroups of pediatric patients with autoinflammatory disorders 2025 ·Journal of Allergy and Clinical Immunology Global ·(unknown), Magali Perret, Sophie Trouillet‐Assant, Marine Villard, Christine Lombard, Lorna Garnier, Anne‐Perrine Foray, (unknown), Rémi Pescarmona, (unknown), Thierry Walzer, Alexandre Bélot, Sébastien Viel	1
2	French protocol for diagnosis and management of type 1 interferonopathies 2025 ·La Revue de Médecine Interne ·Alexandre Bélot, Odile Boespflug‐Tanguy, Guilaine Boursier, Marie Hully, Bénédicte Neven, Florence Renaldo, Héloïse Reumaux, Sébastien Viel, Marie‐Louise Frémond, Isabelle Melki, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
3	NK Cell Immaturity and NKp30 Expression Positively Correlate with Clinical Outcome in Multiple Myeloma Patients from the IFM2009 Clinical Trial 2025 ·European Journal of Immunology ·Marine Villard, Sébastien Viel, Lionel Karlin, Hervé Avet‐Loiseau, Ludovic Martinet, Antoine Marçais, Thierry Walzer	0
4	Assessment of type I interferon response in routine practice in France in 2022 2023 ·RMD Open ·(unknown), Anne‐Perrine Foray, Lorna Garnier, Christine Lombard, É. Hachulla, Brigitte Bader‐Meunier, Sophie Georgin‐Lavialle, Isabelle Melki, Thierry Walzer, Alexandre Bélot, Sébastien Viel	8
5	High-efficiency transgene integration by homology-directed repair in human primary cells using DNA-PKcs inhibition 2023 ·Nature Biotechnology ·Sridhar Selvaraj, (unknown), Sébastien Viel, Sriram Vaidyanathan, Amanda M. Dudek, Marc Gastou, Sarah J. Rockwood, Freja K. Ekman, (unknown), Liwen Xu, Mara Pavel-Dinu, (unknown), M. Kyle Cromer, (unknown), Natalia Gomez‐Ospina, Matthew H. Porteus	40
6	Rescue of Pap-Mas in Systemic JIA Using Janus Kinase Inhibitors, Case Report and Systematic Review 2023 ·Journal of Clinical Medicine ·(unknown), (unknown), (unknown), Maud Tusseau, Rémi Pescarmona, Sophie Collardeau‐Frachon, (unknown), Sébastien Viel, Philippe Reix, (unknown), Alexandre Bélot	8
7	Two patients with allergy to celery — Possible role of carbohydrate determinants and difference between seeds and tuber allergenicity 2022 ·World Allergy Organization Journal ·Paweł Dubiela, (unknown), Merima Bublin, C. Metz‐Favre, Sébastien Viel, Françoise Bienvenu, Christine Häfner, Gabrielle Pauli, Karin Hoffmann‐Sommergruber	3
8	Evaluation of TTV replication as a biomarker of immune checkpoint inhibitors efficacy in melanoma patients 2021 ·PLoS ONE ·Rémi Pescarmona, William Mouton, Thierry Walzer, Stéphane Dalle, (unknown), Karen Brengel‐Pesce, Marine Villard, Christine Lombard, Sophie Trouillet‐Assant, Sébastien Viel	5
9	Cutting Edge: mTORC1 Inhibition in Metastatic Breast Cancer Patients Negatively Affects Peripheral NK Cell Maturation and Number 2021 ·The Journal of Immunology ·Laurie Besson, Benoîte Méry, Magali Morelle, Yamila Rocca, Pierre-Étienne Heudel, Benoît You, Thomas Bachelot, Isabelle Ray‐Coquard, Marine Villard, Emily Charrier, François Parant, Sébastien Viel, Gwenaële Garin, (unknown), David Pérol, Thierry Walzer, Olivier Trédan, Antoine Marçais	9
10	NLRC4 GOF Mutations, a Challenging Diagnosis from Neonatal Age to Adulthood 2021 ·Journal of Clinical Medicine ·(unknown), (unknown), Mathieu Fusaro, Capucine Pïcard, Lorna Garnier, Sébastien Viel, Sophie Collardeau‐Frachon, (unknown), I. Durieu, (unknown), Guillaume Mortamet, (unknown), Alexandre Bélot	10
11	JAK1/2 Inhibition in Severe TAFRO Syndrome: A Case Report 2021 ·Annals of Internal Medicine ·Martin Killian, Sébastien Viel, Émilie Chalayer, Fabien Forest, Sylvain Grange, (unknown), Éric Oksenhendler, P. Cathébras, Stéphane Paul	10
12	Low glycosylated ferritin is a sensitive biomarker of severe COVID-19 2020 ·Cellular and Molecular Immunology ·Maxime Fauter, Sébastien Viel, (unknown), Pierre Pradat, (unknown), Marine Villard, Lorna Garnier, Thierry Walzer, P. Sève, Thomas Henry, Yvan Jamilloux	8
13	Design, production and immunomodulatory potency of a novel allergen bioparticle 2020 ·PLoS ONE ·Véronique Gomord, (unknown), Anne‐Catherine Fitchette, Elizabeth D. Fixman, (unknown), Lorna Garnier, (unknown), Sébastien Viel, (unknown), (unknown), Sylvain Trépout, Brian J. Ward, Ronald van Ree, Loı̈c Faye, Louis‐P. Vézina	12
14	Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient 2020 ·Cellular and Molecular Immunology ·Guillaume Monneret, (unknown), (unknown), (unknown), Florence Ader, Émilie Frobert, Morgane Gossez, Sébastien Viel, Fabienne Venet, Florent Wallet	40
15	Identification of Primary Natural Killer Cell Modulators by Chemical Library Screening with a Luciferase-Based Functional Assay 2018 ·SLAS DISCOVERY ·(unknown), (unknown), Laurie Besson, Rodolphe Alves de Sousa, Nicolas Pietrancosta, Sébastien Viel, Nikaïa Smith, Yves Jacob, Sébastien Nisole, Rupasri Mandal, David S. Wishart, Thierry Walzer, Jean‐Philippe Herbeuval, Pierre‐Olivier Vidalain	13
16	Deletion of Inflammasome Components Is Not Sufficient To Prevent Fatal Inflammation in Models of Familial Hemophagocytic Lymphohistiocytosis 2018 ·The Journal of Immunology ·Sébastien Fauteux‐Daniel, Sébastien Viel, Laurie Besson, Jiang Zhang, Marie Marotel, Anne‐Laure Mathieu, Rémi Pescarmona, Emily Charrier, Thomas Henry, Alexandre Bélot, Thierry Walzer	5
17	Regulation of mTOR, Metabolic Fitness, and Effector Functions by Cytokines in Natural Killer Cells 2017 ·Cancers ·Sébastien Viel, Laurie Besson, Marie Marotel, Thierry Walzer, Antoine Marçais	28
18	Alteration of Natural Killer cell phenotype and function in obese individuals 2016 ·Clinical Immunology ·Sébastien Viel, Laurie Besson, Emily Charrier, Antoine Marçais, Emmanuel Disse, Jacques Bienvenu, Thierry Walzer, Charles Dumontet	90
19	L’association Alt a 1 (Alternaria)–Act d 2 (kiwi) : origine et pertinence clinique possible 2016 ·Revue française d'allergologie ·Annick Barre, F. Bienvenu, (unknown), (unknown), Sébastien Viel, (unknown), Jacques Bienvenu, Pierre Rougé	3
20	T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow 2014 ·The Journal of Experimental Medicine ·Cécile Daussy, Fabrice Faure, Katia Mayol, Sébastien Viel, Georg Gasteiger, Emily Charrier, Jacques Bienvenu, Thomas Henry, Emilie Debien, Uzma Hasan, Jacqueline Marvel, Keigyou Yoh, Satoru Takahashi, Immo Prinz, Simon de Bernard, Laurent Buffat, Thierry Walzer	439

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact